Royal Hobart Hospital
8
2
2
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
25.0%
2 terminated/withdrawn out of 8 trials
33.3%
-53.2% vs industry average
38%
3 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Use of Artificial Intelligence-Guided Echocardiography to assIst cardiovascuLar Patient managEment
Role: collaborator
Mackenzie's Mission: The Australian Reproductive Carrier Screening Project
Role: collaborator
PVRI GoDeep Global Deep Phenotyping Meta-Registry for Pulmonary Hypertension
Role: collaborator
OPTIMIST-A Trial: Minimally-invasive Surfactant Therapy in Preterm Infants 25-28 Weeks Gestation on CPAP
Role: collaborator
A Randomised Study to Assess Betadine in the Groin Wound of Patients Undergoing Primary Varicose Vein Surgery
Role: lead
Local Anaesthetic Following Hernia Repair
Role: lead
A Randomised, Blinded Study on Laparoscopic Mesh Reinforcement for Chronic Groin Pain
Role: lead
U Clip Study - Study to Compare U Clip Anastomosis With Conventional Continuous Prolene Anastomosis
Role: lead
All 8 trials loaded